---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-23-031488"
form_type: "8-K"
ticker: null
cik: "0001584751"
company_name: "Talis Biomedical Corp"
filed_at: "2023-07-05T23:59:59+00:00"
generated_at: "2026-06-13T12:41:32.217831+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Talis Biomedical effects 1-for-15 reverse stock split to regain Nasdaq compliance

## Summary
- Reverse split effective July 5, 2023; shares reduce from ~26.9M to ~1.8M.
- Stock begins trading on post-split basis on Nasdaq on July 6 under symbol TLIS.
- No fractional shares; any fractional interest rounded up to one whole share.
- CUSIP number changed to 87424L207; par value unchanged at $0.0001.
- Split intended to raise per-share price to satisfy Nasdaq minimum bid requirement.

## SEC filing metadata
- accession: 0000950170-23-031488
- form_type: 8-K
- cik: 0001584751
- company_name: Talis Biomedical Corp
- filed_at: 2023-07-05T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1584751/000095017023031488/0000950170-23-031488-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1584751/000095017023031488/tlis-20230705.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-23-031488
- JSON: https://secwatch.observer/filing/0000950170-23-031488.json
- Plain text: https://secwatch.observer/filing/0000950170-23-031488.txt

## Key facts
- Governance Changes
  Talis Biomedical Corp: Filed a certificate of amendment to effect a 1-for-15 reverse stock split of common stock (effective 2023-07-05).
  - Change: charter amendment
  - Effective: 2023-07-05
  source text: On June 30, 2023, Talis Biomedical Corporation (the “Company”) filed a certificate of amendment to the Company’s Amended and Restated Certificate of Incorporation (the “Certificate of Amendment”), with the Secretary of State of the State of Delaware to effect a 1-for-15 reverse stock split of the shares of the Company’s common stock, par value $0.0001 per share, effective as of 5:00 p.m., Eastern Time, on July 5, 2023
  evidence_url: https://www.sec.gov/Archives/edgar/data/1584751/000095017023031488/0000950170-23-031488-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.